Document:

EXHIBIT 10.2

 

AMENDMENT TO LOAN DOCUMENTS

 

THIS AMENDMENT to Loan Documents (this  “Amendment” or the “January 2012 Amendment”) is entered into as of January 23, 2012 (the “January 2012 Amendment Date”), by and between SILICON VALLEY BANK, a California corporation (“Bank” or “Silicon”), and ENCISION INC., a Colorado corporation (“Borrower”).  Borrower’s chief executive office is located at 6797 Winchester Circle, Boulder, CO  80301.

 

RECITALS

 

A.                                    Borrower and Bank are parties to that certain Loan and Security Agreement dated as of November 10, 2006 (as amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”) in effect between Borrower and Bank.

 

B.                                    Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.

 

C.                                    Borrower has requested that Bank amend the Loan Agreement to, among other things: (i) extend the Revolving Line Maturity Date, as set forth in Section 2.1 below; (ii) introduce an additional financial covenant, as set forth in Section 2.2 below; and (iii) modify the form of Compliance Certificate to conform same in respect of the additional financial covenant, as set forth in Section 2.3 below; in each case, all as more fully set forth herein.

 

D.                                    Bank has agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

1.                                      Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement. The term “January 2012 Amendment Date” as defined above hereby is incorporated into the Loan Agreement.

 

1

 

2.                                      Amendments to Loan Documents.

 

2.1                               Extension of Revolving Line Maturity Date. The definition of Revolving Line Maturity Date set forth in Section 13.1 of the Loan Agreement, which definition currently reads as follows (italics added):

 

“  “Revolving Line Maturity Date” is January 23, 2012. ”

 

hereby is amended and restated in its entirety to read as follows:

 

“  “Revolving Line Maturity Date” is March 23, 2012. ”

 

2.2                               Introduction of Additional Financial Covenant.  Effective immediately and at all times from and after the January 2012 Amendment Date, Section 6.9 of the Loan Agreement, which currently reads as follows (italics added):

 

“6.9                        Financial Covenant(s).  Borrower shall maintain, at all times (and tested at any and all times) from and after the December 2011 Amendment Date, Adjusted Liquidity (as defined below) of not less than $250,000.00.  As used herein, the term “Adjusted Liquidity” means, as of any date of determination, the sum of the Excess Availability (as defined below) plus Borrower’s unrestricted cash on deposit at Bank.  As used herein, the term “Excess Availability” means, as of any date of determination, an amount equal to the result of (1) the lower of (y) the maximum Revolving Line amount) and (z) the Borrowing Base, minus (2) the aggregate amount of all outstanding Advances and all applicable Reserves.”

 

hereby is amended and restated in its entirety to read as follows:

 

“6.9                                                Financial Covenant(s).

 

(a) Minimum Adjusted Liquidity.  Borrower shall maintain, at all times (and tested at any and all times) from and after the December 2011 Amendment Date, Adjusted Liquidity (as defined below) of not less than $250,000.00.  As used herein, the term “Adjusted Liquidity” means, as of any date of determination, the sum of the Excess Availability (as defined below) plus Borrower’s unrestricted cash on deposit at Bank.  As used herein, the term “Excess Availability” means, as of any date of determination, an amount equal to the result of (1) the lower of (y) the maximum Revolving Line amount) and (z) the Borrowing Base, minus (2) the aggregate amount of all outstanding Advances and all applicable Reserves.

 

2

 

(b) Minimum Pre-Tax Profit.  Borrower shall achieve, measured as of the last day of each test period set forth below (each, a “Test Period”), Pre-Tax Profit (as defined below) for such test period of not less than the amount set forth below:

 

	
Test Period
    	
 
    	
Minimum Pre-Tax Profit
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
The one month period ending December 31, 2011 
    	
 
    	
$
    	
1.00
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
The two consecutive months period ending January 31,   2012 
    	
 
    	
$
    	
1.00
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Commencing with the month ending February 29,   2012, and continuing with each month thereafter, a Test Period shall be the   three consecutive months period ending on the last day of such month 
    	
 
    	
$
    	
1.00
    	
 
    

 

As defined herein, “Pre-Tax Profit” means, as calculated on a consolidated basis for Borrower and its Subsidiaries for any Test Period taken as a single accounting period and as at any date of determination, the sum of (i) Net Income, plus (ii) income tax expense, plus (iii) stock option expense.”

 

2.3                               Conforming Modification of Form of Compliance Certificate. In order to amend the form of Compliance Certificate to reflect the modification of Section 6.9 of the Loan Agreement effected by Section 2.2 of this Amendment, the currently existing Exhibit E [Form of Compliance Certificate] attached to the Loan Agreement (the “Existing Compliance Certificate Form”) hereby is amended and restated in its entirety to read as set forth on Exhibit E attached to this Amendment (the “Amended Compliance Certificate Form”).  From and after the January 2012 Amendment Date, any and all references in the Loan Documents to Exhibit E attached to the Loan Agreement shall mean and refer to the Amended Compliance Certificate Form instead of the Existing Compliance Certificate Form.

 

3

 

3.                                      Limitation of Amendments.

 

3.1                               The amendments set forth in Section 2, above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document.

 

3.2                               This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents (as amended by this Amendment, as applicable) are hereby ratified and confirmed and shall remain in full force and effect.

 

4.                                      Representations and Warranties.  To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows:

 

4.1                               Immediately after giving effect to this Amendment, (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties expressly relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

 

4.2                               Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Documents, as amended by this Amendment;

 

4.3                               The organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;

 

4.4                               The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Documents, as amended by this Amendment, have been duly authorized;

 

4.5                               The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Documents, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;

 

4.6                               The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Documents, as amended by this Amendment, do not require any order, consent, approval, license, authorization or

 

4

 

validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on either Borrower, except as already has been obtained or made; and

 

4.7                               This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

 

5.                                      Release by Borrower.  Borrower hereby agrees as follows:

 

5.1                               FOR GOOD AND VALUABLE CONSIDERATION, Borrower hereby forever relieves, releases, and discharges Bank and its present or former employees, officers, directors, agents, representatives, attorneys, and each of them, from any and all claims, debts, liabilities, demands, obligations, promises, acts, agreements, costs and expenses, actions and causes of action, of every type, kind, nature, description or character whatsoever, whether known or unknown, suspected or unsuspected, absolute or contingent, arising out of or in any manner whatsoever connected with or related to facts, circumstances, issues, controversies or claims existing or arising from the beginning of time through and including the date of execution of this Amendment (collectively “Released Claims”).  Without limiting the foregoing, the Released Claims shall include any and all liabilities or claims arising out of or in any manner whatsoever connected with or related to the Loan Documents, the Recitals hereto, any instruments, agreements or documents executed in connection with any of the foregoing or the origination, negotiation, administration, servicing and/or enforcement of any of the foregoing.

 

5.2                               In furtherance of this release, Borrower expressly acknowledges and waives any and all rights under Section 1542 of the California Civil Code, which provides as follows:

 

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR EXPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.” (Emphasis added.)

 

(and the equivalent thereof, if any, under the laws of any other applicable jurisdiction).

 

5.3                               By entering into this release, Borrower recognizes that no facts or representations are ever absolutely certain and it may hereafter discover facts in addition to or different from those which it presently knows or believes to be true, but that it is the intention of Borrower hereby to fully, finally and forever settle and release all matters,

 

5

 

disputes and differences, known or unknown, suspected or unsuspected; accordingly, if Borrower should subsequently discover that any fact that it relied upon in entering into this release was untrue, or that any understanding of the facts was incorrect, Borrower shall not be entitled to set aside this release by reason thereof, regardless of any claim of mistake of fact or law or any other circumstances whatsoever.  Borrower acknowledges that it is not relying upon and has not relied upon any representation or statement made by Bank with respect to the facts underlying this release or with regard to any of such party’s rights or asserted rights.

 

5.4                               This release may be pleaded as a full and complete defense and/or as a cross-complaint or counterclaim against any action, suit, or other proceeding that may be instituted, prosecuted or attempted in breach of this release.  Borrower acknowledges that the release contained herein constitutes a material inducement to Bank to enter into this Amendment, and that Bank would not have done so but for Bank’s expectation that such release is valid and enforceable in all events.

 

5.5                               Borrower hereby represents and warrants to Bank, and Bank is relying thereon, as follows:

 

(a)                                  Except as expressly stated in this Amendment, neither Bank nor any agent, employee or representative of Bank has made any statement or representation to Borrower regarding any fact relied upon by Borrower in entering into this Amendment.

 

(b)                                  Borrower has made such investigation of the facts pertaining to this Amendment and all of the matters appertaining thereto, as it deems necessary.

 

(c)                                  The terms of this Amendment are contractual and not a mere recital.

 

(d)                                  This Amendment has been carefully read by Borrower, the contents hereof are known and understood by Borrower, and this Amendment is signed freely, and without duress, by Borrower.

 

(e)                                  Borrower represents and warrants that it is the sole and lawful owner of all right, title and interest in and to every claim and every other matter which it releases herein, and that it has not heretofore assigned or transferred, or purported to assign or transfer, to any person, firm or entity any claims or other matters herein released.  Borrower shall indemnify Bank, defend and hold it harmless from and against all claims based upon or arising in connection with prior assignments or purported assignments or transfers of any claims or matters released herein.

 

6.                                      Fee.  In consideration for Bank entering into this Amendment, Borrower shall pay Bank a fee in the mutually agreed amount of $2,000.00, which fee shall be earned in full and payable concurrently with the execution and delivery of this

 

6

 

Amendment, and all Bank Expenses in connection herewith.  Such fee shall be non-refundable and in addition to all interest and other fees payable to Bank under the Loan Documents.  Bank is authorized to charge such fee and such Bank Expenses to Borrower’s loan account.

 

7.                                      Counterparts.  This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.

 

8.                                      Effectiveness.  This Amendment shall be deemed effective upon the due execution and delivery to Bank of this Amendment by each party hereto.

 

[Remainder of page intentionally left blank; signature page immediately follows.]

 

7

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.

 

	
Borrower:
    
	
 
    
	
ENCISION   INC., a Colorado corporation
    
	
 
    
	
 
    
	
By
    	
/s/ Fred   Perner
    	
 
    
	
Print   Name
    	
Fred   Perner
    	
 
    
	
Title
    	
CEO &   President
    	
 
    
	
 
    
	
 
    
	
Bank:
    
	
 
    
	
SILICON   VALLEY BANK
    
	
 
    
	
 
    
	
By
    	
/s/ Daniel   Harrison
    	
 
    
	
Print   Name
    	
Daniel   Harrison
    	
 
    
	
Title
    	
RM
    	
 
    

 

Signature Page

 

 

Exhibit E

[Amended Compliance Certificate Form]

 

COMPLIANCE CERTIFICATE

 

	
TO:
    	
SILICON   VALLEY BANK
    	
Date: 
    	
 
    	
 
    
	
FROM:
    	
ENCISION   INC.
    	
 
    

 

The undersigned authorized officer of Encision Inc. (“Borrower”) certifies that under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”), (1) Borrower is in complete compliance for the period ending                                with all required covenants except as noted below, (2) there are no Events of Default, (3) all representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date, (4) Borrower, and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 5.9 of the Agreement, and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.  Attached are the required documents supporting the certification.  The undersigned certifies that these are prepared in accordance with generally GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes.  The undersigned acknowledges that no borrowings may be requested at any time or date of determination that Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered.  Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.

 

Please indicate compliance status by circling Yes/No under “Complies” column.

 

	
Reporting Covenant
    	
 
    	
Required
    	
 
    	
Complies
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Monthly   financial statements with Compliance Certificate
    	
 
    	
Monthly within 30 days
    	
 
    	
Yes  No
    
	
Annual   financial statements (CPA Audited) + CC
    	
 
    	
FYE   within 120 days
    	
 
    	
Yes  No
    
	
10-Q,   10-K and 8-K
    	
 
    	
Within   5 days after filing with SEC
    	
 
    	
Yes  No
    
	
A/R & A/P Agings &   Reconciliations & Inventory Reports
    	
 
    	
Monthly   within 30 days
    	
 
    	
Yes  No
    
	
Borrowing   Base Certificates
    	
 
    	
Monthly   within 30 days
    	
 
    	
Yes  No
    
	
Monthly   sales report
    	
 
    	
Monthly   within 5 days
    	
 
    	
Yes  No
    
	
Transaction   Reports, Borrowing Base Certificate, and Rolling 13-week cash flow forecast,   of Borrower
    	
 
    	
Weekly
    	
 
    	
Yes  No
    

 

	
The   following intellectual property was registered after the Effective Date (if   no registrations, state “None”)
    

 

 

	
Financial Covenants
    	
 
    	
Required
    	
 
    	
Actual
    	
 
    	
Complies
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Adjusted   Liquidity equals the sum of the Excess Availability (as set forth in   (III) below) plus Borrower’s unrestricted cash on deposit at Bank (as   set forth in (IV) below).

 

I.   As of the date hereof, the result of (1) the lower of (y) the   maximum Revolving Line amount ($2,000,000.00) and (z) the Borrowing   Base, minus (2) the aggregate amount of all outstanding Advances is   $                          .

 

II.   As of the date hereof, the aggregate amount of all applicable Reserves (per   the Bank) is   $                          .

 

III.   As of the date hereof, Borrower’s “Excess Availability” (which equals the   result of (I) above less (II) above is $              

 

IV.   As of the date hereof, the amount of Borrower’s unrestricted cash on deposit   at Bank is   $                      .
    	
 
    	
Greater   than or equal to $250,000.00
    	
 
    	
$
    	
 
    	
 
    	
Yes  No
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Minimum Pre-Tax Profit,   measured as of the last day of each Test Period, of not less than the   following amount:
    	
 
    	
Test Period ending:

 
    	
 
    	
 
    	
$
    	
 
    	
 
    	
Yes  No
    
	
 
    	
December 31, 2011 (trailing   one month):
    	
$1.00
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
January 31, 2012 (trailing   two months):
    	
$1.00
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
February 29, 2012,   and each month thereafter (trailing three months):
    	
$1.00
    	
 
    	
 
    	
 
    	
 
    	
 
    
											

 

The financial covenants analysis and information set forth in Schedule 1 attached hereto is true and accurate as of the date of this Certificate.

 

 

The following are the exceptions with respect to the certification above:  (If no exceptions exist, state “No exceptions to note.”)

 

 

 

 

	
ENCISION   INC.
    	
 
    	
BANK   USE ONLY
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Received   by:
    	
 
    
	
By:
    	
 
    	
 
    	
 
    	
AUTHORIZED SIGNER
    
	
Name:
    	
 
    	
 
    	
Date:
    	
 
    
	
Title:
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Verified:
    	
 
    
	
 
    	
 
    	
 
    	
AUTHORIZED SIGNER
    
	
 
    	
 
    	
Date:
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Compliance   Status: 
    	
Yes    No
    
								

 

{form amended per January 2012 Amendment}Exhibit 10.1

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT is made and entered
into this February 6, 2012 by and between Kiwa Bio-Tech Products Group Corp., a Delaware corporation having its principal place
of business at 310 N. Indian Hill Blvd., #702 Claremont, California and Li Wei, an individual, whose address is 6 Hao Lou, #1805,
Dao Xiang Yuan, Hai Dian Qu, Beijing, China (“Executive”), with reference to the following facts:

 

RECITALS

 

WHEREAS, Company is primarily engaged in the
business of developing, manufacturing, distributing and marketing innovative, cost-effective and environmentally safe bio-technological
products for the agricultural, stockbreeding, natural resources and environmental protection markets, primarily in China; and

 

WHEREAS, Company desires to employ Executive
and to ensure the continued availability to Company of Executive’s services, and Executive desires to accept such employment
from Company and render such services, all in accordance with and subject to the terms and conditions herein set forth;

 

NOW, THEREFORE, in consideration of the promises
and of the mutual covenants contained herein, and for other good and valuable consideration, receipt of which is hereby acknowledged,
Company and Executive do hereby agree as follows:

 

AGREEMENT

1. Term of Employment.

1.01. Specified Term. Company employs Executive,
and Executive accepts employment with Company, for a period of 3 years beginning on January 1, 2012, and ending on December 31,
2014.

 

1.02. Earlier Termination. This Agreement may
be terminated earlier as hereinafter provided.

 

1.03. Continuing Effect. Notwithstanding any
termination of this Agreement except for termination under Sections 8.01 and 8.02, at the end of the Term or otherwise, the provisions
of Sections 2.04(b) and 2.07 shall remain in full force and effect and the provisions of Section 2.07shall be binding upon the
legal representatives, successors and assigns of the Executive.

 

1.04. “Employment Term” Defined.
“Employment term” refers to the entire period of employment of Executive by Company, whether for the periods provided
above, or whether terminated earlier as hereinafter provided or extended by mutual Agreement between Company and Executive.

    	 

    	 

    

2. Duties and Obligations of
Executive.

2.01. General Duties. Executive shall serve
as the President, Chief Executive Officer (CEO) of Kiwa Bio-Tech Products Group, Corp. (“Kiwa Bio-Tech”). In his capacity
as President, CEO of Kiwa Bio-Tech, Executive shall do and perform all services, acts, or things necessary or advisable to manage
and conduct the business of Company, including the hiring and firing of all employees and officers of Company, subject at all times
to the policies set by Company’s Board of Directors, and to the consent of the Board when required by the terms of this Agreement.

 

 

2.02. Matters Requiring Consent of Board of
Directors. Executive shall not, without specific approval of Company's Board of Directors, do or contract to do any of the following:

 

(a) Borrow on behalf of Company in each transaction
an amount in excess of $500,000;

 

(b) Permit any customer of Company to become
indebted to Company in an amount in excess of $500,000;

 

(c) Purchase capital equipment for amounts
in excess of the amounts budgeted for expenditure by the Board of Directors;

 

(d) Sell any single capital asset of Company
having a market value in excess of $300,000 or a total of capital assets during a fiscal year having a market value in excess of
$1,00,000; and

 

(e) Commit Company to the expenditure of more
than $200,000 in the development and sale of new products or services.

 

2.03. Devotion to Company’s Business.

 

(a) Executive shall devote his entire productive
time, ability, and attention to the business of Company during the term of this Agreement.

 

(b) Executive shall not engage in any other
business duties or pursuits whatsoever, or directly or indirectly render any services of a business, commercial, or professional
nature to any other person or organization, whether for compensation or otherwise, without the prior written consent of Company's
Board of Directors. However, the expenditure of reasonable amounts of time for educational, charitable, or professional activities
shall not be deemed a breach of this Agreement if those activities do not materially interfere with the services required under
this Agreement and shall not require the prior written consent of Company's Board of Directors.

 

(c) This Agreement shall not prohibit Executive
from making passive personal investments or conducting private business affairs if those activities do not materially interfere
with the services required under this Agreement. However, Executive shall not directly or indirectly acquire, hold, or retain any
interest in any business competing with or similar in nature to the business of Company.

    	-2-

    	 

    
 

 

2.04. Competitive Activities.

 

(a) During the term of this Agreement Executive
shall not, directly or indirectly, either as an Executive, Company, consultant, agent, principal, partner, stockholder, corporate
officer, director, or in any other individual or representative capacity, engage or participate in any business that is in competition
in any manner whatsoever with the business of Company.

 

(b) Executive agrees that during the term of
this Agreement and for a period of one year after termination of this Agreement, Executive shall not directly or indirectly solicit,
hire, recruit, or encourage any other Executive of Company to leave Company.

 

2.05. Uniqueness of Executive’s Services.
Executive represents and agrees that the services to be performed under the terms of this Agreement are of a special, unique, unusual,
extraordinary, and intellectual character that gives them a peculiar value, the loss of which cannot be reasonably or adequately
compensated in damages in an action at law. Executive therefore expressly agrees that Company, in addition to any other rights
or remedies that Company may possess, shall be entitled to injunctive and other equitable relief to prevent or remedy a breach
of this Agreement by Executive.

 

2.06. Indemnification for Negligence or Misconduct.
Executive shall indemnify and hold Company harmless from all liability for loss, damage, or injury to persons or property resulting
from the negligence or misconduct of Executive.

 

2.07. Trade Secrets.

 

(a) The parties acknowledge and agree that
during the term of this Agreement and in the course of the discharge of his duties hereunder, Executive shall have access to and
become acquainted with financial, personnel, sales, scientific, technical and other information regarding formulas, patterns, compilations,
programs, devices, methods, techniques, operations, plans and processes that are owned by Company, actually or potentially used
in the operation of Company's business, or obtained from third parties under an Agreement of confidentiality, and that such information
constitutes Company's ''trade secrets.''

 

(b) Executive specifically agrees that he shall
not misuse, misappropriate, or disclose in writing, orally or by electronic means, any trade secrets, directly or indirectly, to
any other person or use them in any way, either during the term of this Agreement or at any other time thereafter, except as is
required in the course of his employment.

 

(c) Executive acknowledges and agrees that
the sale or unauthorized use or disclosure in writing, orally or by electronic means, of any of Company's trade secrets obtained
by Executive during the course of his employment under this Agreement, including information concerning Company's actual or potential
work, services, or products, the facts that any such work, services, or products are planned, under consideration, or in production,
as well as any descriptions thereof, constitute unfair competition. Executive promises and agrees not to engage in any unfair competition
with Company, either during the term of this Agreement or at any other time thereafter.

(d) Executive further agrees that all files,
records, documents, drawings, specifications, equipment, software, and similar items whether maintained in hard copy or on line
relating to Company's business, whether prepared by Executive or others, are and shall remain exclusively the property of Company
and that they shall be removed from the premises or, if kept on-line, from the computer systems of Company only with the express
prior written consent of Company's Board of Directors.

    	-3-

    	 

    

 

2.08. Services as Consultant. Following the
employment term or Executive's retirement, and if the employment term has not been terminated for cause, Executive shall make his
advice and counsel available to Company for such a period as the parties may mutually agree to. The parties agree that this advice
and counsel shall not entail full time service and shall be consistent with Executive's retirement status.

 

2.09. Use of Executive’s Name.

 

(a) Company shall have the right to use the
name of Executive as part of the trade name or trademark of Company if it should be deemed advisable to do so. Any trade name or
trademark, of which the name of Executive is a part, that is adopted by Company during the employment of Executive may be used
thereafter by Company for as long as Company deems advisable.

 

(b) Executive shall not, either during the
term of this Agreement or at any time thereafter, use or permit the use of his name in the trade name or trademark of any other
enterprise if that other enterprise is engaged in a business similar in any respect to that conducted by Company, unless that trade
name or trademark clearly indicates that the other enterprise is a separate entity entirely distinct from and not to be confused
with Company and unless that trade name or trademark excludes any words or symbols stating or suggesting prior or current affiliation
or connection by that other enterprise or its Executives with Company.

3. Obligations of Company.

3.01. General Description. Company shall provide
Executive with the compensation, incentives, benefits, and business expense reimbursement specified elsewhere in this Agreement.

 

3.02. Office and Staff. Company shall provide
Executive with office space, office equipment, and administrative support suitable to Executive's position and adequate for the
performance of his duties.

 

3.03. Indemnification of Losses of Executive.
Company shall indemnify Executive for all necessary expenditures or losses incurred by Executive in direct consequence of the discharge
of his duties on Company's behalf.

4. Compensation of Executive.

4.01. Annual Salary.

    	-4-

    	 

    
 

(a) As compensation for the services to be
performed hereunder, Executive shall receive a salary at the rate of $96,000 per annum, of which $72,000 shall be paid in equal
monthly installments of $6,000 during the period of employment, prorated for any partial employment period, and $24,000 shall be
paid as an annual performance bonus in three months after each employment year.

 

(b) Executive shall receive such annual increases
in salary as may be determined by Company's Board of Directors in its sole discretion at its annual meeting.

 

4.02. Salary Continuation During Disability.
If Executive for any reason whatsoever becomes permanently disabled so that he is unable to perform the duties prescribed herein,
Company agrees to pay Executive his monthly installments of salary, payable in the same manner as provided for the payment of salary
herein, for a period of up to six (6) months from the date of disability or until the expiration of the employment term provided
for herein, whichever occurs sooner.

 

4.03. Repayment of Disallowed Salary. In the
event that any portion of the compensation paid by Company to Executive is disallowed as an income tax deduction on an income tax
return of Company, Executive agrees to immediately repay to Company the full amount of that portion.

5. Executive Incentives.

5.01. Annual Cash Bonus Based on Performance.

 

(a) At the beginning of any fiscal year during
the employment term as herein provided, Company’s Board of Directors shall set forth for Executive goals and objectives to
be accomplished by Executive during that year. For the successful completion of all goals and objectives by the end of that year,
Executive shall receive a performance bonus provided for in Section 4.01 for his services in addition to any other compensation
which he is entitled to receive hereunder. The amount of bonus shall be determined by the Board of Directors. This bonus shall
be paid within one month after the annual meeting of the Board of Directors.

 

(b) If the employment term is terminated by
Company for cause, Executive shall not be entitled to any portion of the annual cash bonus for the fiscal year in which that termination
occurs. However, if this Agreement should expire or be terminated for reasons other than cause, Executive shall be entitled to
a percentage of the annual cash bonus equal to the percentage of the goals and objectives accomplished.

 

(c) As additional compensation, Company agrees
to grant Executive each year certain number of stock options pursuant to Company’s Stock Incentive Plan and the board resolutions
on stock option allocation plan each fiscal year. All terms and conditions of Company’s Stock Incentive Plan, including
but not limited to option grant, exercise and any other items are applicable for Executive as a plan participant. 

    	-5-

    	 

    

6. Executive Benefits.

6.01. Annual Vacation. Executive shall be entitled
to two (2) week vacation time each year with full pay. Executive may be absent from his employment for vacation only at such times
as Company's President shall determine from time to time. If Executive is unable for any reason to take the total amount of authorized
vacation time during any year, he may accrue that time and add it to vacation time for any following year or may receive a cash
payment in an amount equal to the amount of annual salary attributable to that period.

 

6.02. Illness. On completion of one (1) year
in the service of Company, Executive shall be entitled to five (5) days per year as sick leave with full pay. Sick leave may not
be accumulated or accrued for any following year.

 

6.03. Employee Benefit Programs. Executive
is entitled to participate in any pension, 401(k), insurance or other employee benefit plan that is maintained by Company for its
executive officers, including programs of life and medical insurance and reimbursement of membership fees in civic, social and
professional organizations

 

6.04. Insurance. Company shall provide to Executive
and pay premiums on Company's group medical insurance policy offered through Company, covering Executive and Executive's dependents.

 

6.05. Severance Package. If Executive's employment
with Company is terminated pursuant to Section 8.03 or 8.04, Executive shall be entitled to three (3) month severance package consisting
of Executive's compensation and all benefits as provided for in Sections 4, 5 and 6 and all Executive's remaining unvested options
shall vest immediately. Payments shall be made monthly or in a lump sum payment at the Board's sole discretion. In the event severance
is paid in a lump sum, the cash amount excluding insurance benefits shall be paid at the present value for the time remaining in
the 3-month severance agreement based on the current prime interest rate as charged by the Federal Reserve Bank in New York.

7. Business Expenses.

7.01. Lump-Sum Entertainment Fund.

 

(a) It is understood and agreed by the parties
that the services required by Company will require Executive to incur entertainment expenses on behalf of Company. Company hereby
agrees to and shall make available to Executive for this purpose the sum of $50,000 per annum, payable in such amounts and at such
times as Executive shall request.

 

(b) Executive shall, however, furnish to Company
adequate records and other documentary evidence required by federal and state statutes and regulations for the substantiation of
each such expenditure as an income tax deduction.

    	-6-

    	 

    

 

7.02. Reimbursement of Other Business Expenses.

 

(a) Company shall promptly reimburse Executive
for all other reasonable business expenses incurred by Executive in connection with the business of Company.

 

(b) Each such expenditure shall be reimbursable
only if it is of a nature qualifying it as a proper deduction on the federal and state income tax return of Company.

 

(c) Each such expenditure shall be reimbursable
only if Executive furnishes to Company adequate records and other documentary evidence required by federal and state statutes and
regulations issued by the appropriate taxing authorities for the substantiation of each such expenditure as an income tax deduction.

 

7.03. Repayment of Disallowed Expenses. In
the event that any expenses paid for Executive or any reimbursement of expenses paid to Executive shall, on audit or other examination
of Company's income tax returns, be determined not to be allowable deductions from Company's gross income, and in the further event
that this determination shall be acceded to by the Company or made final by the appropriate federal or state taxing authority or
a final judgment of a court of competent jurisdiction, and no appeal is taken from the judgment or the applicable period for filing
notice of appeal has expired, Executive shall repay to Company the full amount of the disallowed expenses.

8. Termination of Employment.

8.01. Termination for Cause.

 

(a) Company reserves the right to terminate
this Agreement if Executive willfully breaches or habitually neglects the duties which he is required to perform under the terms
of this Agreement; or commits such acts of dishonesty, fraud, misrepresentation or other acts of moral turpitude as would prevent
the effective performance of his duties.

 

(b) Company may at its option terminate this
Agreement for the reasons stated in this Section by giving written notice of termination to Executive without prejudice to any
other remedy to which Company may be entitled either at law, in equity, or under this Agreement.

 

(c) The notice of termination required by this
section shall specify the ground for the termination and shall be supported by a statement of all relevant facts.

 

(d) Termination under this section shall be
considered ''for cause'' for the purposes of this Agreement.

 

8.02. Failure to Meet Profit Standard.

 

(a) If the net operating profits of Company
for any annual accounting period of Company shall be less than the net operating profits in the previous fiscal year by 20% percent,
Company at its option may terminate this Agreement by giving written notice of termination to Executive.

    	-7-

    	 

    

 

(b) The term ''net operating profits,'' as
used herein, means the net operating profits after taxes as determined and certified by the independent certified public accountants
regularly retained by Company in accordance with sound accounting principles and in accordance with the past accounting practices
of Company.

 

(c) Termination under this section shall be
considered ''for cause'' for the purposes of this Agreement.

 

8.03. Termination Without Cause.

 

(a) This Agreement shall be terminated upon
the death of Executive.

 

(b) Company reserves the right to terminate
this Agreement not less than six (6) months after Executive suffers any physical or mental disability that would prevent the performance
of his essential job duties under this Agreement, unless reasonable accommodation can be made to allow Executive to continue working.
Such a termination shall be effected by giving twenty (20) days' written notice of termination to Executive. Termination pursuant
to this provision shall not prejudice Executive's rights to continued compensation pursuant to Section 4.02 of this Agreement.

 

(c) Termination under this section shall not
be considered ''for cause'' for the purposes of this Agreement.

 

8.04. Effect of Merger, Transfer of Assets,
or Dissolution.

 

(a) This Agreement shall not be terminated
by any voluntary or involuntary dissolution of Company resulting from either a merger or consolidation in which Company is not
the consolidated or surviving corporation, or a transfer of all or substantially all of the assets of Company.

 

(b) In the event of any such merger or consolidation
or transfer of assets, Company's rights, benefits, and obligations hereunder shall be assigned to the surviving or resulting corporation
or the transferee of Company's assets.

 

8.05. Payment On Termination Notwithstanding
any provision of this Agreement, if Company terminates this Agreement, it shall pay Executive an amount equal to six (6) months
salary at the then current rate of compensation.

 

8.06. Termination by Executive. Executive may
terminate his obligations under this Agreement by giving Company at least three (3) months notice in advance.

    	-8-

    	 

    

9. General Provisions.

9.01. Notices. Notices and Addresses.
All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently
given if delivered to the addressees in person, by Federal Express or similar receipted delivery, by facsimile delivery or, if
mailed, postage prepaid, by certified mail, return receipt requested, as follows:

 

To Company:

Kiwa Bio-Tech Products Group, Corp.

 

310 N. Indian Hill Blvd., #702

 

Claremont, California

 

To Executive:

Wei Li

____________________

____________________

 

or to such other address as either of them,
by notice to the other may designate from time to time. The transmission confirmation receipt from the sender's facsimile machine
shall be evidence of successful facsimile delivery. Time shall be counted to, or from, as the case may be, the delivery in person
or by mailing

 

9.02. Attorneys' Fees and Costs. If any legal
action is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys'
fees, costs, and necessary disbursements in addition to any other relief to which that party may be entitled. This provision shall
be construed as applicable to the entire Agreement.

 

9.03. Modifications. Any modification of this
Agreement will be effective only if it is in writing signed by the party to be charged.

 

9.04. Effect of Waiver. The failure of either
party to insist on strict compliance with any of the terms, covenants, or conditions of this Agreement by the other party shall
not be deemed a waiver of that term, covenant, or condition, nor shall any waiver or relinquishment of any right or power at any
one time or times be deemed a waiver or relinquishment of that right or power for all or any other times.

 

9.05. Partial Invalidity. If any provision
in this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remaining provisions
shall nevertheless continue in full force without being impaired or invalidated in any way.

 

9.06. Law Governing Agreement. This Agreement
shall be governed by and construed in accordance with the laws of the State of California.

 

9.07. Counterparts. This Agreement may be executed
in one or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same
instrument. The execution of this Agreement may be by actual or facsimile signature.

    	-9-

    	 

    

 

9.08. Additional Documents. The parties hereto
shall execute such additional instruments as may be reasonably required by their counsel in order to carry out the purpose and
intent of this Agreement and to fulfill the obligations of the parties hereunder.

 

9.09. Section and Paragraph Headings. The section
and paragraph headings in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of
this Agreement.

 

9.10. Arbitration. Except for a claim for equitable
relief, any controversy, dispute or claim arising out of or relating to this Agreement, or its interpretation, application, implementation,
breach or enforcement which the parties are unable to resolve by mutual agreement, shall be settled by submission by either party
of the controversy, claim or dispute to binding arbitration in Los Angeles County, California (unless the parties agree in writing
to a different location), before three arbitrators in accordance with the rules of the American Arbitration Association then in
effect. In any such arbitration proceeding the parties agree to provide all discovery deemed necessary by the arbitrators. The
decision and award made by the arbitrators shall be final, binding and conclusive on all parties hereto for all purposes, and judgment
may be entered thereon in any court having jurisdiction thereof.

 

9.11. Entire Agreement. This Agreement supersedes
any and all other Agreements, either oral or in writing, between the parties hereto with respect to the employment of Executive
by Company, and contains all of the covenants and Agreements between the parties with respect to that employment in any manner
whatsoever. Each party to this Agreement acknowledges that no representations, inducements, promises, or Agreements, orally or
otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein, and that no other
Agreement, statement, or promise not contained in this Agreement shall be valid or binding.

 

IN WITNESS WHEREOF, Company and Executive have
executed this Agreement as of the date and year first above written.

 

COMPANY:

Kiwa Bio-Tech Products Group Corp.

/s/ Steven Ning Ma

Steven Ning Ma

(Chief Financial Officer, Authorized Signature)

February 6, 2012

 

EXECUTIVE:

/s/ Wei Li

Wei LI

February 6, 2012

(Signature)

 

    	-10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}]]